Capital Growth Management Portfolio holdings
Top Buys
| 1 |
Citigroup
C
|
+$134M |
| 2 |
AGN
Allergan plc
AGN
|
+$125M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$103M |
| 4 |
American Airlines Group
AAL
|
+$92.8M |
| 5 |
NVR
NVR
|
+$92.1M |
Top Sells
| 1 |
Morgan Stanley
MS
|
+$302M |
| 2 |
Whirlpool
WHR
|
+$193M |
| 3 |
Nu Skin
NUS
|
+$129M |
| 4 |
Aptiv
APTV
|
+$100M |
| 5 |
Micron Technology
MU
|
+$92.2M |
Sector Composition
| 1 | Consumer Discretionary | 38.05% |
| 2 | Real Estate | 17.81% |
| 3 | Technology | 12.46% |
| 4 | Financials | 11.15% |
| 5 | Industrials | 10.06% |
Similar funds
Capital Growth Management's Q1 2014 Portfolio in Review
As of Q1 2014, Capital Growth Management held 90 positions worth $3.73B, down 3.5% from $3.87B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Capital Growth Management withdrew a net $247M in Q1 2014, closing 24 positions and reducing 18 holdings. Its most notable exit was Nu Skin, an estimated $129M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 42% a quarter earlier, followed by Real Estate and Technology.
Against the trend, Capital Growth Management opened a new position in Allergan plc worth $130M.
- Capital Growth Management's largest Q1 2014 buy was Allergan plc: 630,000 shares worth $130M.
- Capital Growth Management added most to Citigroup in Q1 2014, an estimated $134M increase.
- Capital Growth Management's biggest Q1 2014 reduction was Morgan Stanley, cutting an estimated $302M.
- Capital Growth Management fully exited Nu Skin in Q1 2014, selling an estimated $129M.
- Capital Growth Management's ten largest holdings make up 44% of its $3.73B portfolio in Q1 2014.
- Capital Growth Management opened 26 new positions and closed 24 in Q1 2014.
- Capital Growth Management's portfolio value fell 3.5% quarter-over-quarter to $3.73B.
Based on Capital Growth Management's 13F filing for Q1 2014, filed 14 May 2014.